市場調查報告書
商品編碼
1182111
全球腎上腺皮質類固醇市場規模研究與預測:按產品、給藥途徑、應用和地區分析,2022-2029Global Corticosteroids Market Size study & Forecast, by Product, Route of Administration, Application and Regional Analysis, 2022-2029 |
腎上腺皮質產生的一種類固醇激素,用於治療多種疾病,如腎髒病、自身免疫性疾病、胃腸病、皮膚病、腦水腫等。
這些類固醇還用於替代療法和器官移植。 腎上腺皮質激素市場因慢性病和感染增加、治療藥物應用增加等因素而不斷擴大。 預計在整個預測期內,製藥行業正在進行的研究和開發將開闢新的市場潛力。
根據聯合國發布的2020年報告,預計到2025年,目前的72億人口將增至82億。 因此,到 2020 年底,全球慢性病負擔預計將上升至 57%。 根據美國疾病控制和預防中心 2020 年的報告,大約有 2500 萬美國人患有哮喘。 這大約是三分之一的美國人、8% 的成年人和 7% 的兒童。 哮喘影響著超過 2000 萬 18 歲及以上的美國人。 然而,與長期使用皮質類固醇相關的風險因素將阻礙整個 2022-2029 年預測期內的市場增長。
研究全球皮質類固醇市場的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於與生活方式相關的疾病發病率上升、經濟發展和醫療保健成本上升,北美在收入方面佔據主導地位。 然而,由於技術先進產品的高度採用,預計亞太地區將成為增長最快的地區。
這項研究的目的是揭示近年來不同細分市場和國家/地區的市場規模,並預測未來幾年的價值。 本報告旨在捕捉被調查國家行業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的潛在微觀市場機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Corticosteroids Market is valued at approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Corticosteroids are a group of steroidal hormones that are generated in the adrenal cortex and are used to treat a variety of diseases, including kidney disease, autoimmune illness, GIT disease, skin disease, cerebral edema, and others. These steroids are also used in replacement treatment and organ transplantation. The Corticosteroids market is expanding because of factors such increase in the prevalence of chronic & infectious diseases and a rise in therapeutical product application. Continuing R&D in the pharmaceutical sector is predicted to open up new market possibilities throughout the forecast period.
According to the United Nations report 2020, the anticipated human population would rise from 7.2 billion now to 8.2 billion by 2025. By the end of 2020, this causes the worldwide burden of chronic illnesses to increase to 57%. About 25 million Americans have asthma, according to the Centers for Disease Control and Prevention's 2020 report. This equates to around 1 in 13 Americans, which includes 8% of adults and 7% of children. Asthma affects over 20 million American individuals who are 18 years of age and older. However, risk factors associated with Corticosteroids on Prolonged use stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Corticosteroids Market study includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the increasing incidence of lifestyle-related diseases and developed economy, increasing health care expenditure. However, Asia Pacific is expected to be the fastest growing region due to the high adoption of technologically advanced products.
Major market players included in this report are:
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sumitomo Corporation
GlaxoSmithKline plc
Novartis AG
Bayer AG Pharmaceutical
Sanofi S.A.
AstraZeneca plc
Merck & Co., Inc.
Cipla Inc.
Recent Developments in the Market:
Global Corticosteroids Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product, Route of Administration, Application, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.
The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Glucocorticoids
Mineralocorticoids
By Route of Administration:
Topical steroids
Inhaled steroids
Oral forms
Systemic forms
Others
By Application:
Rheumatology indications
Skin allergies
Endocrinology
Gastroenterology
Acute respiratory diseases
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable